Dysregulation of Glypicans and Notum in Osteoarthritis: Plasma Levels, Bone Marrow Mesenchymal Stromal Cells and Osteoblasts

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2024 May 24

PMID 38786073

Authors

Irene Gonzalez-Guede

Maria Lopez-Ramos

Luis Rodriguez-Rodriguez

Lydia Abasolo

Arkaitz Mucientes

Benjamin Fernandez-Gutierrez

Affiliations

Soon will be listed here.

Abstract

In this study of the alterations of Glypicans 1 to 6 (GPCs) and Notum in plasma, bone marrow mesenchymal stromal cells (BM-MSCs) and osteoblasts in Osteoarthritis (OA), the levels of GPCs and Notum in the plasma of 25 patients and 24 healthy subjects were measured. In addition, BM-MSCs from eight OA patients and eight healthy donors were cultured over a period of 21 days using both a culture medium and an osteogenic medium. Protein and gene expression levels of GPCs and Notum were determined using ELISA and qPCR at 0, 7, 14 and 21 days. GPC5 and Notum levels decreased in the plasma of OA patients, while the BM-MSCs of OA patients showed downexpression of GPC6 and upregulation of Notum. A decrease in GPC5 and Notum proteins and an increase in GPC3 were found. During osteogenic differentiation, elevated GPCs 2, 4, 5, 6 and Notum mRNA levels and decreased GPC3 were observed in patients with OA. Furthermore, the protein levels of GPC2, GPC5 and Notum decreased, while the levels of GPC3 increased. Glypicans and Notum were altered in BM-MSCs and during osteogenic differentiation from patients with OA. The alterations found point to GPC5 and Notum as new candidate biomarkers of OA pathology.

References

Filmus J, Capurro M, Rast J . Glypicans. Genome Biol. 2008; 9(5):224. PMC: 2441458. DOI: 10.1186/gb-2008-9-5-224. View

Boudin E, Fijalkowski I, Piters E, Van Hul W . The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases. Semin Arthritis Rheum. 2013; 43(2):220-40. DOI: 10.1016/j.semarthrit.2013.01.004. View

Murphy J, Dixon K, Beck S, Fabian D, Feldman A, Barry F . Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 2002; 46(3):704-13. DOI: 10.1002/art.10118. View

Corr M . Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat Clin Pract Rheumatol. 2008; 4(10):550-6. DOI: 10.1038/ncprheum0904. View

Held A, Glas A, Dietrich L, Bollmann M, Brandstadter K, Grossmann T . Targeting β-catenin dependent Wnt signaling via peptidomimetic inhibitors in murine chondrocytes and OA cartilage. Osteoarthritis Cartilage. 2018; 26(6):818-823. DOI: 10.1016/j.joca.2018.02.908. View

Palazzo C, Nguyen C, Lefevre-Colau M, Rannou F, Poiraudeau S . Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016; 59(3):134-138. DOI: 10.1016/j.rehab.2016.01.006. View

Sun Y, Xu K, He M, Fan G, Lu H . Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt/β-Catenin Signaling. Oncol Res. 2017; 26(4):565-572. PMC: 7844840. DOI: 10.3727/096504017X15044461944385. View

De Robertis M, Arigoni M, Loiacono L, Riccardo F, Calogero R, Feodorova Y . Novel insights into Notum and glypicans regulation in colorectal cancer. Oncotarget. 2015; 6(38):41237-57. PMC: 4747403. DOI: 10.18632/oncotarget.5652. View

Traister A, Shi W, Filmus J . Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. Biochem J. 2007; 410(3):503-11. DOI: 10.1042/BJ20070511. View

10.

Tornero-Esteban P, Peralta-Sastre A, Herranz E, Rodriguez-Rodriguez L, Mucientes A, Abasolo L . Altered Expression of Wnt Signaling Pathway Components in Osteogenesis of Mesenchymal Stem Cells in Osteoarthritis Patients. PLoS One. 2015; 10(9):e0137170. PMC: 4564164. DOI: 10.1371/journal.pone.0137170. View

11.

Udomsinprasert W, McConachie E, Ngarmukos S, Theerawattanapong N, Tanavalee A, Honsawek S . Plasma and Joint Fluid Glypican-3 Are Inversely Correlated with the Severity of Knee Osteoarthritis. Cartilage. 2019; 12(4):505-511. PMC: 8461156. DOI: 10.1177/1947603519841679. View

12.

Wang Y, Fan X, Xing L, Tian F . Wnt signaling: a promising target for osteoarthritis therapy. Cell Commun Signal. 2019; 17(1):97. PMC: 6697957. DOI: 10.1186/s12964-019-0411-x. View

13.

Hunter D, McDougall J, Keefe F . The symptoms of osteoarthritis and the genesis of pain. Rheum Dis Clin North Am. 2008; 34(3):623-43. PMC: 2597216. DOI: 10.1016/j.rdc.2008.05.004. View

14.

Hunter D, Felson D . Osteoarthritis. BMJ. 2006; 332(7542):639-42. PMC: 1403209. DOI: 10.1136/bmj.332.7542.639. View

15.

Torisu Y, Watanabe A, Nonaka A, Midorikawa Y, Makuuchi M, Shimamura T . Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF. Cancer Sci. 2008; 99(6):1139-46. PMC: 11158900. DOI: 10.1111/j.1349-7006.2008.00814.x. View

16.

Uccelli A, Moretta L, Pistoia V . Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2009; 8(9):726-36. DOI: 10.1038/nri2395. View

17.

Song H, Shi W, Xiang Y, Filmus J . The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem. 2004; 280(3):2116-25. DOI: 10.1074/jbc.M410090200. View

18.

Duan P, Bonewald L . The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 2016; 77(Pt A):23-29. PMC: 4958569. DOI: 10.1016/j.biocel.2016.05.015. View

19.

Moverare-Skrtic S, Nilsson K, Henning P, Funck-Brentano T, Nethander M, Rivadeneira F . Osteoblast-derived NOTUM reduces cortical bone mass in mice and the locus is associated with bone mineral density in humans. FASEB J. 2019; 33(10):11163-11179. PMC: 6766646. DOI: 10.1096/fj.201900707R. View

20.

Capurro M, Martin T, Shi W, Filmus J . Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J Cell Sci. 2014; 127(Pt 7):1565-75. DOI: 10.1242/jcs.140871. View